# PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2

**URL:** <https://schizophreniasupport.discourse.group/t/pde10a-inhibition-in-schizophrenia-a-randomised-placebo-controlled-phase-2/7554>\
**Category:** Medications\
**Created:** [July 31, 2026, 5:13pm UTC](https://schizophreniasupport.discourse.group/t/pde10a-inhibition-in-schizophrenia-a-randomised-placebo-controlled-phase-2/7554 "2026-07-31T17:13:45Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![firemonkey](https://yyz2.discourse-cdn.com/flex012/user_avatar/schizophreniasupport.discourse.group/firemonkey/32/1229_2.png) [@firemonkey](https://schizophreniasupport.discourse.group/u/firemonkey)\
**Post date:** [July 31, 2026, 5:13pm UTC](https://schizophreniasupport.discourse.group/t/pde10a-inhibition-in-schizophrenia-a-randomised-placebo-controlled-phase-2/7554/1 "2026-07-31T17:13:45Z")

</div>

> **[PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2...](https://pubmed.ncbi.nlm.nih.gov/42533223/)**
>
> Clinicaltrials.gov identifier: NCT05278156; registration date: 2022-02-09.